Eisele, Yvonne S.
Monteiro, Cecilia
Fearns, Colleen
Encalada, Sandra E.
Wiseman, R. Luke
Powers, Evan T.
Kelly, Jeffery W.
Article History
First Online: 4 September 2015
Competing interests
: J.W.K. and E.T.P. discovered tafamidis, and J.W.K. founded FoldRx to commercialize it. FoldRx is now owned by Pfizer, in which both J.W.K. and E.T.P. have a financial interest. J.W.K. is a shareholder and a paid consultant for Pfizer, which sells tafamidis. J.W.K. and E.T.P. receive royalty payments from the sale of tafamidis. Y.S.E., C.M., C.F., S.E.E. and R.L.W. declare no competing financial interests.